Beyond COVID and cancer: In which indications will we see mRNA technology succeed next? And what technological advances might next-generation mRNA platforms offer over those used in the COVID-19 vaccines?
Novartis is teaming up with the NHS to make the PCSK9 inhibitor Leqvio available for UK heart patients who struggle to control their LDL cholesterol with existing drugs.